The Alfuzosin Hydrochloride Extended, cataloged under National Stock Number 6505-01-566-9383, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals. Government technical data includes 1 verified specification, sourced from the Federal Logistics Information System (FLIS). This item has 5 commercial cross-references from 5 manufacturers, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-566-9383 |
| Primary Part Number | NDC76282-0302-01 |
| Item Name | Alfuzosin Hydrochloride Extended |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals |
| Status | ACTIVE |
| General Characteristics Item Description | DO NOT CHEW OR CRUSH TABLET |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC76282-0302-01 PRIMARY | Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals (USA) |
| 9083 | Defense Logistics Agency Directorate of Medical Materiel Defense Supply Center Philadelphia (USA) |
| 6505NCM082804 | Defense Medical Standardization Board (USA) |
| NDC69097-0844-07 PRIMARY | Cipla Usa Inc (USA) |
| NDC59212-0200-10 PRIMARY | Concordia Pharmaceuticals Inc. |
NSN 6505-01-566-9383 is a Alfuzosin Hydrochloride Extended, manufactured by Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-566-9383 has 5 cross-referenced part numbers: NDC76282-0302-01 (Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals), 9083 (Defense Logistics Agency Directorate of Medical Materiel Defense Supply Center Philadelphia), 6505NCM082804 (Defense Medical Standardization Board), NDC69097-0844-07 (Cipla Usa Inc), NDC59212-0200-10 (Concordia Pharmaceuticals Inc.).
There are 12 known substitutes for 6505-01-566-9383: 5120-00-144-2098, 5310-00-402-8744, 6810-00-853-8751 and 9 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC76282-0302-01: Part Name Assigned by Controlling Agency: ALFUZOSIN HCL UROXATRAL EX-RELEASE 10MG BT 100TT; Special Features: 10MG ACTIVE INGREDIENT, BOTTLE OF 100"S; TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AND RENAL CALCULI; STORE AT CONTROLLED RM TEMP; PROTECT FROM LIGHT AND MOISTURE; TAKE ONE DAILY AFTER THE SAME MEAL; General Characteristics Item Description: DO NOT CHEW OR CRUSH TABLET. 3 total characteristics are documented in the Federal Logistics Information System.